Although myeloid HIF-1α has been recently implicated in promoting DSS-induced colitis (43, 44), we hypothesize that these disparate results are likely due to different phases of inflammation under examination, and/or different effects of the gene promoters driving Cre-mediated recombination. This evidence concerns the gene HIF1A and colitis.